Writer
Katherashala Dharan Kumar
PharmD
Katherashala Dharan Kumar, PharmD A dedicated Clinical Researcher with expertise in medical and scientific writing clinical trials, drug safety, and healthcare innovation. Actively contributes to research publications and clinical documentation focused on improving patient outcomes through evidence-based practices and ethical research standards. Believe that every complex data point has a human story waiting to be told. Focusing on providing actionable insights for clinical research
18
Articles written or reviewed
About Katherashala
Katherashala Dharan Kumar (PharmD) is a writer at Pharmacally, with 18 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Katherashala Dharan Kumar
Clinical TrialsSarepta Advances siRNA Pipeline with Early FSHD and DM1 Trial Data
Clinical TrialsDizal Reports Positive Phase 3 Sunvozertinib Results in NSCLC
Health TidingsEvotec’s Just – Evotec Biologics Wins BARDA BioMaP Contract for Ebola and Sudan Virus Antibodies
Clinical TrialsBiohaven Completes Enrollment in Phase 2 Trial of Taldefgrobep for Obesity
Health TidingsGalimedix Reports Improved PK Profile for Next-Generation Oral Aβ Modulator Prodrug
Health TidingsLilly’s Retatrutide Shows Up to 2.0% A1C Reduction and 16.8% Weight Loss in Phase 3 Diabetes Trial
New Drug ApprovalJ&J’s Oral IL-23 Therapy ICOTYDE Wins FDA Approval for Plaque Psoriasis
Clinical TrialsCapricor Reports New HOPE-3 Data Showing Deramiocel Improves Cardiac and Functional Outcomes in DMD
New Drug ApprovalJ&J’s Niraparib–Abiraterone Combo Approved in EU for BRCA-Mutated mHSPCOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala